User

Meta-Analysis of the Role of Varenicline in Smoking Cessation

Muhammad Zainul Lafif, Bhisma Murti, Hanung Prasetya

Abstract

Background: Smoking is the leading cause of premature death in both developed and developing countries. Smoking cessation efforts can be classified into pharmacological and therapeutic strategies. Varencline is the latest discovery for pharmacological therapy for smoking cessation programs. This study aims to determine the role of varenicline on smoking cessation efforts.

Subjects and Method: This was a systematic review and meta-analysis conducted using PRISMA flow diagrams. Search articles through journal databases including: Google Scholar, MEDLINE/ PubMed, Science Direct, Scopus, and Spinger Link by selecting articles published in 2011-2021. The keywords used are “varenicline” OR “pharmacotherapy” AND tobacco OR smoke OR smoked OR smoker AND “smoking cessation”. The research instrument used to assess smoking cessation efforts was the Fagerstrom Test for Nicotine Dependence (FTND). The inclusion criteria were full paper articles with Randomized Controlled Trial (RCT) research methods, the relationship measure used was Mean SD, the intervention given was varenicline, the research subjects were adult smokers who wanted to quit smoking. Eligible articles were analyzed using the Revman 5.3 application.

Results: Meta-analysis of 9 articles showed results (SMD -0.11; 95% CI = -0.17 to -0.05; p<0.001).

Conclusion: Varenicline has a statistically significant effect in reducing the frequency of smoking per day.

Keywords: Varenicline, smoking cessation, quitting smoking

Correspondence: Muhamad Zainul Lafif. Masters Program in Public Health. Universitas Sebelas Maret, Jl.Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: zainullafif@gmail.com. Mobile: 0821­37179433.

Indonesian Journal of Medicine (2021), 06(04): 354-363
https://doi.org/10.26911/theijmed.2021.06.04.01

 

Full Text:

PDF

References

Ahmed S, Virani S, Kotapati VP, Bachu R, Adnan M, Khan AM, Zubair A, et al. (2018). Efficacy and safety of varenicline for smoking cessation in schizophrenia: A meta analysis. Front Psychiatry. 9(9) : 1–10. https://doi.org/10.3389/fpsyt.2018.00428.


Alexandridi F, Tsantila S, Pepelassi E (2018). Smoking cessation and response to periodontal treatment. Aust Dent J. 63(2): 140–149. https://doi.org/10.1111/adj.12568


Arifianti T, Soemanto RB, Prasetya H (2019). Application of theory of planned behavior on factors affecting smoking behavior among high school students. Int J Public Health. 23(10): 104. https//doi.org/10.26911/the6thicph.02.11.


Arifianti T, Soemanto RB, Prasetya H (2019). The contextual effect of school on smoking behavior among male high school students. J Health Promot Behav. 4(1): 76–84. https://doi.org/10.26911/thejhpb.2019.04.01.08.


Bohadana A, Freier-Dror Y, Peles V, Babai P, Izbicki G (2020). Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial: Six-week varenicline preloading for smoking cessation. J Eclinm. 19(11) : 1–10. https://doi.org/10.1016/j.eclinm.2019.11.021


Drope J, Neil W, Schluger N (2018). The tobacco atlas sixth edition. Vital Strategies. 6(2): 20–31. https://www.tobaccoatlas.org.


Ebbert JO, Hughes JR, West RJ, Rennard SI, Russ C, McRae TD, Treadow J, et al. (2015). Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. J Am Med Assoc. 313(7): 687–694. https://doi.org/10.1001/jama.2015.280.


Gray KM, Baker NL, Mcclure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ (2019). Efficacy and safety of varenicline for adolescent smoking cessation: randomized clinical trial. J Am Med Assoc. 173(12): 1146–1153. https://doi.org/10.1001/jamapediatrics.2019.3553.


Gunawan S (2012). Peran varenicline terhadap upaya berhenti merokok. Ebers Papyrus. 18(1): 57–68. https://journal.untar.ac.id/index.php/ebers_papyrus/artic le/view/643/584.


Guo K, Li J, Chen N, Li Y, Yang K, Li X (2021). The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta-analysis of nine randomized controlled trials. Int J Clin Pract. 75(11): 11–13. https://doi.org/10.1111/ijcp.14594.


Huang Y, Li W, Yang L, Jiang Y, Wu Y (2012). Long-term efficacy and safety of varenicline for smoking cessation: a systematic review and meta analysis of randomized controlled trials. Berlin Print. 20(4): 355–365. https://doi.org/10.10 07/s10389-011-0476-5


Islami SU, Prasetya H, Murti B (2019). Schools have contextual influence on smoking behavior among high school students in Dumai, Riau. J Health Promot Behav. 4(3): 212-223. https://doi.org/10.26911/thejhpb.2019.04.03.06.


Jordan CJ, Xi ZX (2018). Discovery and development of varenicline for smoking cessation. Expert Opin Drug Discov. 13(7): 671–683. https://doi.org/10.1080/17460441.2018.1458-090.


Murti B (2018). Prinsip dan metode riset epidemiologi (epidemiological research principles and methods). Surakarta: Bintang Fajar Offset.


Putra AI, Hanriko R, Kurniawaty E (2019). pengaruh efek paparan asap rokok elektrik dibandingkan paparan asap rokok konvensional terhadap gambar-an histopatologi paru mencit jantan (mus musculus). Majority. 8(1): 90–94. http://juke.kedokteran.unila.ac.id/.


Rosita R, Suswardany DL, Abidin Z (2012). Penentu keberhasilan berhenti merokok pada mahasiswa (Determinants of success in quitting smoking in college students). Kemas (online). 8(1): 1–9. http://journal.unnes.ac.id/ nju/index.php/kemas.


Vogeler T, McClain C, Evoy KE (2016). Combination bupropion sr and varenicline for smoking cessation: a systematic review. Am J Drug Alcohol Abuse. 42(2): 129 - 139. https://doi.org/10.-3109/00952990.2015.1117480.


WHO (2020). Penggunaan tembakau dan COVID-19. World Health Organization. https://www.who.int/indonesia/news/detail/11052020-pernyataan-who-penggunaan-tembakau-dan-covid-19.


Wiratmoko MR, Susanto AD, Yunus F, Ginting TT, Pulmonologi D (2017). Efikasi penggunaan varenicline pada program berhenti merokok. uji acak tersamar tunggal plasebo kontrol a randomized, single-blind, plasebo controlled trial (Efficacy of varenicline use in smoking cessation programs. single-blind, placebo-controlled trial a randomized, single-blind, placebo controlled trial). J Respir Indo. 37(2): 145 156. http://arsip.jurnalrespirolo-gi.org/wpcontent/uploads/2017/10/JRI-Apr-2017-37-2-145-56.pdf.


Wiratmoko MR, Yunu F, Susanto AD, Ginting TT, Kekalih A (2016). Efikasi varenicline, α4β2 reseptor asetilkolin nikotinik agonis parsial, vs plasebo untuk berhenti merokok. sebuah desain studi dengan randomized controlled trial (Efficacy of vareni-cline, a partial agonist nicotinic acetylcholine receptor 4β2, vs placebo for smoking cessation. a study design with a randomized controlled trial). J Kedokt Kesehat. 12(1): 1-22. https://jurnal.umj.ac.id/index.php/JKK/article/vie w/1544.


Zhao X, Dichtl FF, Foran HM (2020). Pre-dicting smoking behavior: intention and future self-continuity among Austrians. Psychol Health Med. 10(11): 1–25. https://doi.org/10.1080/13548506.2020.1842898.

Refbacks

  • There are currently no refbacks.